SpringWorks Therapeutics
SWTX
#3574
Rank
โ‚น306.79 B
Marketcap
โ‚น4,072
Share price
0.00%
Change (1 day)
32.11%
Change (1 year)

P/E ratio for SpringWorks Therapeutics (SWTX)

P/E ratio as of July 2025 (TTM): -13.2

According to SpringWorks Therapeutics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -13.2366. At the end of 2023 the company had a P/E ratio of -7.09.

P/E ratio history for SpringWorks Therapeutics from 2019 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2023-7.0941.97%
2022-4.99-71.25%
2021-17.4-74.85%
2020-69.0610.23%
2019-9.72

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
-5.98-54.83%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.